Search Results - "MINASSIAN, Berge A"
-
1
Brain Dopamine–Serotonin Vesicular Transport Disease and Its Treatment
Published in The New England journal of medicine (07-02-2013)“…Four siblings with gait dystonia and other neurologic deficits were found to have a mutation in SLC18A2, a gene encoding a transporter of serotonin and…”
Get full text
Journal Article -
2
Neuronal ceroid lipofuscinoses
Published in Epileptic disorders (01-09-2016)“…The neuronal ceroid lipofuscinoses (NCL) are neurodegenerative conditions that associate cognitive decline, progressive cerebellar atrophy, retinopathy, and…”
Get full text
Journal Article -
3
Diagnostic yield of genetic testing in epileptic encephalopathy in childhood
Published in Epilepsia (Copenhagen) (01-05-2015)“…Summary Objective Epilepsy is a common neurologic disorder of childhood. To determine the genetic diagnostic yield in epileptic encephalopathy, we performed a…”
Get full text
Journal Article -
4
Amylopectinosis of the fatal epilepsy Lafora disease resists autophagic glycogen catabolism
Published in EMBO molecular medicine (16-05-2024)“…In this Correspondence, B. Minassian and colleagues report that GHF201, an autophagy activator shown to diminish abnormal glycogen aggregates in a mouse model…”
Get full text
Journal Article -
5
Pathogenesis of Lafora Disease: Transition of Soluble Glycogen to Insoluble Polyglucosan
Published in International journal of molecular sciences (11-08-2017)“…Lafora disease (LD, OMIM #254780) is a rare, recessively inherited neurodegenerative disease with adolescent onset, resulting in progressive myoclonus epilepsy…”
Get full text
Journal Article -
6
Lafora disease in miniature Wirehaired Dachshunds
Published in PloS one (02-08-2017)“…Lafora disease (LD) is an autosomal recessive late onset, progressive myoclonic epilepsy with a high prevalence in the miniature Wirehaired Dachshund. The…”
Get full text
Journal Article -
7
Ppp1r3d deficiency preferentially inhibits neuronal and cardiac Lafora body formation in a mouse model of the fatal epilepsy Lafora disease
Published in Journal of neurochemistry (01-06-2021)“…Mammalian glycogen chain lengths are subject to complex regulation, including by seven proteins (protein phosphatase‐1 regulatory subunit 3, PPP1R3A through…”
Get full text
Journal Article -
8
Global characterization of copy number variants in epilepsy patients from whole genome sequencing
Published in PLoS genetics (12-04-2018)“…Epilepsy will affect nearly 3% of people at some point during their lifetime. Previous copy number variants (CNVs) studies of epilepsy have used array-based…”
Get full text
Journal Article -
9
Inhibiting glycogen synthesis prevents lafora disease in a mouse model
Published in Annals of neurology (01-08-2013)“…Lafora disease (LD) is a fatal progressive myoclonus epilepsy characterized neuropathologically by aggregates of abnormally structured glycogen and proteins…”
Get full text
Journal Article -
10
Laforin targets malin to glycogen in Lafora progressive myoclonus epilepsy
Published in Disease models & mechanisms (01-01-2023)“…Glycogen is the largest cytosolic macromolecule and is kept in solution through a regular system of short branches allowing hydration. This structure was…”
Get full text
Journal Article -
11
Skeletal Muscle Glycogen Chain Length Correlates with Insolubility in Mouse Models of Polyglucosan-Associated Neurodegenerative Diseases
Published in Cell reports (Cambridge) (30-04-2019)“…Lafora disease (LD) and adult polyglucosan body disease (APBD) are glycogen storage diseases characterized by a pathogenic buildup of insoluble glycogen…”
Get full text
Journal Article -
12
PTG protein depletion rescues malin-deficient Lafora disease in mouse
Published in Annals of neurology (01-03-2014)“…Ubiquitin ligases regulate quantities and activities of target proteins, often pleiotropically. The malin ubiquitin E3 ligase is reported to regulate…”
Get full text
Journal Article -
13
Hyperphosphorylation of Glucosyl C6 Carbons and Altered Structure of Glycogen in the Neurodegenerative Epilepsy Lafora Disease
Published in Cell metabolism (07-05-2013)“…Laforin or malin deficiency causes Lafora disease, characterized by altered glycogen metabolism and teenage-onset neurodegeneration with intractable and…”
Get full text
Journal Article -
14
Transition from glycogen to starch metabolism in Archaeplastida
Published in Trends in plant science (01-01-2014)“…•Starch evolved from glycogen in the host cytosol after plastid endosymbiosis.•A chlamydial debranching enzyme was recruited for crystalline polysaccharide…”
Get full text
Journal Article -
15
Alleviation of a polyglucosan storage disorder by enhancement of autophagic glycogen catabolism
Published in EMBO molecular medicine (07-10-2021)“…This work employs adult polyglucosan body disease (APBD) models to explore the efficacy and mechanism of action of the polyglucosan‐reducing compound 144DG11…”
Get full text
Journal Article -
16
The Novel Neuronal Ceroid Lipofuscinosis Gene MFSD8 Encodes a Putative Lysosomal Transporter
Published in American journal of human genetics (01-07-2007)“…The late-infantile–onset forms are the most genetically heterogeneous group among the autosomal recessively inherited neurodegenerative disorders, the neuronal…”
Get full text
Journal Article -
17
Structural basis of glycogen branching enzyme deficiency and pharmacologic rescue by rational peptide design
Published in Human molecular genetics (15-10-2015)“…Glycogen branching enzyme 1 (GBE1) plays an essential role in glycogen biosynthesis by generating α-1,6-glucosidic branches from α-1,4-linked glucose chains,…”
Get full text
Journal Article -
18
Epileptic Encephalopathy Caused by Mutations in the Guanine Nucleotide Exchange Factor DENND5A
Published in American journal of human genetics (01-12-2016)“…Epileptic encephalopathies are a catastrophic group of epilepsies characterized by refractory seizures and cognitive arrest, often resulting from abnormal…”
Get full text
Journal Article -
19
Abnormal glycogen chain length pattern, not hyperphosphorylation, is critical in Lafora disease
Published in EMBO molecular medicine (01-07-2017)“…Lafora disease (LD) is a fatal progressive epilepsy essentially caused by loss‐of‐function mutations in the glycogen phosphatase laforin or the ubiquitin E3…”
Get full text
Journal Article -
20
The history of progressive myoclonus epilepsies
Published in Epileptic disorders (01-09-2016)“…The history of the progressive myoclonus epilepsies (PMEs) spans more than a century. However, the recent history of PMEs begins with a consensus statement…”
Get full text
Journal Article